About Us | Contact

Xue Ming Investigator

Neurology with Special Qualifications in Child Neurology Ocean Medical Center NPI1346314507
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$8,118.11
from 14 payments in the last 6 years

Total Cash or Cash Equivalent

$6,398.48
from 4 payments in the last 6 years

Total In-kind Items & Services

$1,719.63
from 10 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
11/18/2021 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $550.00 Details
Payment from GENZYME CORPORATION
Payment Record ID 843521899
09/05/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $5708.50 Details
Payment from Amicus Therapeutics, Inc.
Payment Record ID 699827685
07/25/2019 Research In-kind items and services Drug $50.00 Details
Payment from Otsuka Pharmaceutical Development & Commercialization, Inc.
Paymment Research Study A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF BREXPIPRAZOLE IN TREATMENT OF CHILDREN AND ADOLESCENTS WITH IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Payment Record ID 696051007
07/25/2019 Research In-kind items and services Drug $50.00 Details
Payment from Otsuka Pharmaceutical Development & Commercialization, Inc.
Paymment Research Study A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF BREXPIPRAZOLE IN TREATMENT OF CHILDREN AND ADOLESCENTS WITH IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Payment Record ID 696051005
07/25/2019 Research In-kind items and services Drug $312.52 Details
Payment from Otsuka Pharmaceutical Development & Commercialization, Inc.
Paymment Research Study A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF BREXPIPRAZOLE IN TREATMENT OF CHILDREN AND ADOLESCENTS WITH IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Payment Record ID 696051001
07/24/2019 Research In-kind items and services Drug $120.00 Details
Payment from Otsuka Pharmaceutical Development & Commercialization, Inc.
Paymment Research Study A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF BREXPIPRAZOLE IN TREATMENT OF CHILDREN AND ADOLESCENTS WITH IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Payment Record ID 696050999
07/24/2019 Research In-kind items and services Drug $124.28 Details
Payment from Otsuka Pharmaceutical Development & Commercialization, Inc.
Paymment Research Study A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF BREXPIPRAZOLE IN TREATMENT OF CHILDREN AND ADOLESCENTS WITH IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Payment Record ID 696050997
07/24/2019 Research In-kind items and services Drug $808.60 Details
Payment from Otsuka Pharmaceutical Development & Commercialization, Inc.
Paymment Research Study A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF BREXPIPRAZOLE IN TREATMENT OF CHILDREN AND ADOLESCENTS WITH IRRITABILITY ASSOCIATED WITH AUTISM SPECTRUM DISORDER
Payment Record ID 696050993
12/12/2019 General (Non-Research) Cash or cash equivalent Food and Beverage $124.98 Details
Payment from JAZZ PHARMACEUTICALS INC.
Payment Record ID 684187661
05/04/2019 General (Non-Research) Cash or cash equivalent Food and Beverage $15.00 Details
Payment from JAZZ PHARMACEUTICALS INC.
Payment Record ID 684185435
05/24/2019 General (Non-Research) In-kind items and services Food and Beverage $8.63 Details
Payment from JAZZ PHARMACEUTICALS INC.
Payment Record ID 684169373
02/21/2018 General (Non-Research) In-kind items and services Food and Beverage $125.59 Details
Payment from Allergan Inc.
Payment Record ID 601811926
05/30/2017 General (Non-Research) In-kind items and services Food and Beverage $101.46 Details
Payment from Allergan Inc.
Payment Record ID 470888379
02/26/2016 General (Non-Research) In-kind items and services Food and Beverage $18.55 Details
Payment from Jazz Pharmaceuticals Inc.
Payment Record ID 405610336
;